Patent · US Active

Thienopyrazoles

US7928231B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Aventis Pharmaceuticals Inc. · US

Inventors

John Gerard Jurcak · Bethlehem, US
Matthieu Barrague · New Brunswick, US
Timothy Alan Gillespy · Fryeburg, US
Michael Edwards · Suffolk, US
Kwon Yon Musick · Raritan, US
Philip Marvin Weintraub · Hackettstown, US
Yan Du · Bound Brook, US
Ramalinga M. Dharanipragada · Montgomery, US
Ashfaq Parkar · Piscataway, US

Key dates

Filing date	Mar 26, 2009
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Mar 26, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.